BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nkanga CI, Fisch A, Rad-malekshahi M, Romic MD, Kittel B, Ullrich T, Wang J, Krause RWM, Adler S, Lammers T, Hennink WE, Ramazani F. Clinically established biodegradable long acting injectables: An industry perspective. Advanced Drug Delivery Reviews 2020;167:19-46. [DOI: 10.1016/j.addr.2020.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Machine learning directed drug formulation development. Adv Drug Deliv Rev 2021;175:113806. [PMID: 34019959 DOI: 10.1016/j.addr.2021.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Muddineti OS, Omri A. Current trends in PLGA based long-acting injectable products: The industry perspective. Expert Opin Drug Deliv 2022. [PMID: 35534912 DOI: 10.1080/17425247.2022.2075845] [Reference Citation Analysis]
3 Moore TL, Cook AB, Belotti E, Palomba R, Manghnani P, Spanò R, Brahmachari S, Di Francesco M, Palange AL, Di Mascolo D, Decuzzi P. Shape-specific microfabricated particles for biomedical applications: a review. Drug Deliv and Transl Res . [DOI: 10.1007/s13346-022-01143-4] [Reference Citation Analysis]
4 Abuhamdan RM, Al-Anati BH, Al Thaher Y, Shraideh ZA, Alkawareek MY, Abulateefeh SR. Aqueous core microcapsules as potential long-acting release systems for hydrophilic drugs. Int J Pharm 2021;606:120926. [PMID: 34303818 DOI: 10.1016/j.ijpharm.2021.120926] [Reference Citation Analysis]
5 Krovi SA, Johnson LM, Luecke E, Achilles SL, van der Straten A. Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention. Adv Drug Deliv Rev 2021;176:113849. [PMID: 34186143 DOI: 10.1016/j.addr.2021.113849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang X, Bao Q, Sung Suh M, Kastellorizios M, Wang R, Burgess DJ. Novel adapter method for in vitro release testing of in situ forming implants. Int J Pharm 2022;:121777. [PMID: 35489601 DOI: 10.1016/j.ijpharm.2022.121777] [Reference Citation Analysis]
7 Cagnon ME, Curia S, Serindoux J, Cros JM, Ng F, Lopez-Noriega A. Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables. Pharmaceutics 2021;13:605. [PMID: 33922166 DOI: 10.3390/pharmaceutics13050605] [Reference Citation Analysis]
8 Wang X, Burgess DJ. Drug release from in situ forming implants and advances in release testing. Adv Drug Deliv Rev 2021;:113912. [PMID: 34363860 DOI: 10.1016/j.addr.2021.113912] [Reference Citation Analysis]
9 Shi Y, Lu A, Wang X, Belhadj Z, Wang J, Zhang Q. A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharm Sin B 2021;11:2396-415. [PMID: 34522592 DOI: 10.1016/j.apsb.2021.05.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ibrahim TM, El-Megrab NA, El-Nahas HM. An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization. Pharm Dev Technol 2021;26:709-28. [PMID: 34176433 DOI: 10.1080/10837450.2021.1944207] [Reference Citation Analysis]
11 Li Z, Mu H, Weng Larsen S, Jensen H, Østergaard J. An in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants. Int J Pharm 2021;609:121183. [PMID: 34653562 DOI: 10.1016/j.ijpharm.2021.121183] [Reference Citation Analysis]
12 Gupta D, Prabhakar B, Wairkar S. Non-oral routes, novel formulations and devices of contraceptives: An update. J Control Release 2022:S0168-3659(22)00191-2. [PMID: 35378212 DOI: 10.1016/j.jconrel.2022.03.057] [Reference Citation Analysis]
13 Han S, Mei L, Quach T, Porter C, Trevaskis N. Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles. Pharm Res 2021;38:1497-518. [PMID: 34463935 DOI: 10.1007/s11095-021-03093-x] [Reference Citation Analysis]
14 Bufton J, Jung S, Evans JC, Bao Z, Aguiar D, Allen C. Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel. European Journal of Pharmaceutical Sciences 2021;162:105808. [DOI: 10.1016/j.ejps.2021.105808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kolluru LP, Atre P, Rizvi SAA. Characterization and Applications of Colloidal Systems as Versatile Drug Delivery Carriers for Parenteral Formulations. Pharmaceuticals (Basel) 2021;14:108. [PMID: 33573103 DOI: 10.3390/ph14020108] [Reference Citation Analysis]
16 Wang L, Che K, Liu Y. Pharmacokinetics, distribution and efficacy of triptolide PLGA microspheres after intra-articular injection in a rat rheumatoid arthritis model. Xenobiotica 2021;51:703-15. [PMID: 33938387 DOI: 10.1080/00498254.2021.1923860] [Reference Citation Analysis]